JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1993; 21:1199-1204
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saito, D
Right arrow Articles by Haraoka, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, D
Right arrow Articles by Haraoka, S

Effects of oral theophylline on sick sinus syndrome

D Saito, K Matsubara, H Yamanari, N Obayashi, S Uchida, K Maekawa, T Sato, K Mizuo, H Kobayashi, and S Haraoka

Department of Cardiovascular Medicine, Okayama University Medical School, Japan.

OBJECTIVES. We sought to determine the effect of theophylline on cardiac pauses in sick sinus syndrome. BACKGROUND. Sick sinus syndrome, a relatively benign condition, is usually treated with pacemaker implantation without any proved effectiveness. Thus, an appropriate pharmacologic therapy would be useful. METHODS. Theophylline (200 to 400 mg/day for 1 month) was initially administered orally to 17 patients with sick sinus syndrome, which is manifested by sinus pauses of > 2.5 s. Eleven of the 17 patients subsequently received theophylline for an additional 8 to 37 months. Twenty-four-hour Holter recordings were obtained before treatment, at the end of 1 month of treatment and then at 6-month intervals. RESULTS. Theophylline decreased the frequency of sinus pauses from 256 +/- 230 to 23 +/- 62 pauses per 24 h and decreased the duration of the longest pauses from 4.7 +/- 1.8 to 2.2 +/- 0.97 s after 1 month of treatment. Subjective symptoms associated with cardiac pauses disappeared in 16 of 17 patients. Ventricular premature beats increased in frequency but did not last longer than two beats. Three patients experienced adverse effects. Nine of the 11 patients receiving long-term treatment had a good outcome, but 2 patients required a pacemaker because of the reappearance of long sinus pauses. CONCLUSIONS. The results suggest that oral theophylline may be beneficial for the treatment of patients with sick sinus syndrome.


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
M. Pasic, M. Musci, H. Siniawski, B. Edelmann, T. Tedoriya, and R. Hetzer
Transient sinus node dysfunction after the Cox-maze III procedure in patients with organic heart disease and chronic fixed atrial fibrillation
J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1040 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Alboni, C. Menozzi, M. Brignole, N. Paparella, G. Gaggioli, G. Lolli, and R. Cappato
Effects of Permanent Pacemaker and Oral Theophylline in Sick Sinus Syndrome : The THEOPACE Study: A Randomized Controlled Trial
Circulation, July 1, 1997; 96(1): 260 - 266.
[Abstract] [Full Text]

Home page
 CirculationHome page
B. D. Bertolet, L. Belardinelli, E. A. Franco, W. W. Nichols, R. A. Kerensky, and J. A. Hill
Selective Attenuation by N-0861 (N6-Endonorboran-2-yl-9-Methyladenine) of Cardiac A1 Adenosine Receptor–Mediated Effects in Humans
Circulation, May 15, 1996; 93(10): 1871 - 1876.
[Abstract] [Full Text]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1993 by the American College of Cardiology Foundation.